|
Market Closed -
Nasdaq
01:30:00 11/04/2026 am IST
|
5-day change
|
1st Jan Change
|
|
120.23 USD
|
-0.48%
|
 |
+4.51%
|
+4.51%
|
|
08/04 |
UMB Announces Conference Call to Discuss First Quarter 2026 Results
|
BU
| |
08/04 |
Autonomous Research Initiates Coverage on UMB Financial With Outperform Rating, $135 Price Target
|
MT
| |
07/04 |
RBC Lifts Price Target on UMB Financial to $138 From $134, Keeps Outperform Rating
|
MT
| |
10/03 | |
FA
| |
27/02 |
Tranche Update on UMB Financial Corporation's Equity Buyback Plan announced on April 29, 2025.
|
CI
| |
04/02 |
UMB Financial Insider Sold Shares Worth $2,408,024, According to a Recent SEC Filing
|
MT
| |
28/01 |
UMB Financial Corporation, Q4 2025 Earnings Call, Jan 28, 2026
| | |
28/01 |
UMB Financial Keeps Quarterly Dividend at $0.43 a Share, Payable April 1 to Holders of Record March 10
|
MT
| |
28/01 |
UMB: Q4 Earnings Snapshot
|
AQ
| |
28/01 |
UMB Financial Q4 Adjusted Earnings, Revenue Rise
|
MT
| |
28/01 |
Earnings Flash (UMBF) UMB Financial Corporation Posts Q4 Adjusted EPS $3.08 per Share, vs. FactSet Est of $2.70
|
MT
| |
28/01 |
Earnings Flash (UMBF) UMB Financial Corporation Reports Q4 Revenue $720.9M, vs. FactSet Est of $677.8M
|
MT
| |
28/01 |
UMB Financial Corporation Reports Fourth Quarter and Full-Year 2025 Results
|
BU
| |
28/01 |
UMB Financial Corporation Declares Common and Preferred Dividends
|
BU
| |
28/01 |
UMB Financial Corporation Announces Net Charge-Offs for the Fourth Quarter Ended December 31, 2025
|
CI
| |
28/01 |
UMB Financial Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2025
|
CI
| |
28/01 |
UMB Financial Corporation Declares Quarterly Dividend, Payable on April 1, 2026
|
CI
| |
28/01 |
UMB Financial Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
|
CI
| |
12/01 |
RBC Capital Adjusts Price Target on UMB Financial to $134 From $128, Maintains Outperform Rating
|
MT
| |
08/01 |
UMB Announces Conference Call to Discuss Fourth Quarter 2025 Results
|
BU
| |
13/12 |
UMB Financial Insider Sold Shares Worth $415,072, According to a Recent SEC Filing
|
MT
| |
10/12 | |
FA
| |
09/12 |
Umb Financial Insider Sold Shares Worth $1,760,751, According to a Recent SEC Filing
|
MT
| |
02/12 |
Bristol-Myers' Bid to Dismiss Lawsuit Related to Celgene Acquisition Rejected by US Judge
|
MT
| |
06/11 |
The Market Can't Make Up Its Mind
|  |
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
